quality assessment of biologics and biosimilars at atomic level
Published 5 years ago • 553 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
2:22
coherus bioscience - biosimilar and biologics - 3d animation
-
3:12
biosimilars: critical quality attributes
-
38:15
biosimilars and biologics
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
39:16
professor angela thomas: "regulation of biologics & biosimilars"
-
3:00
biosimilars: complex copycat drugs
-
1:00:29
continuous manufacturing reduces costs for an emerging biosimilar company
-
8:07
biosimilars | what is a biosimilar? | gastrointestinal society
-
4:12
the basics of biosimilars
-
4:41
biologics, unbranded biologics, and biosimilars - what is the difference?
-
5:20
data requirements for biosimilars
-
3:07
the promise of biosimilars
-
3:33
biosimilars: manufacturing and inherent variation
-
0:41
similarity of biosimilars and biologics
-
1:28
fast facts about the quality of biosimilars – amgen science
-
7:21
biologic drugs and biosimilars
-
20:06
biologics and biosimilars: extrapolation of indications – information for healthcare providers
-
14:19
regulatory pathway for biosimilars
-
4:20
the biosimilar development process
-
2:28
what are biologic and biosimilar drugs?
-
25:21
biosimilars - simplified overview